Kummer Andrew E, Grams Morgan, Lutsey Pamela, Chen Yuan, Matsushita Kunihiro, Köttgen Anna, Folsom Aaron R, Coresh Josef
Divisions of Renal Diseases and Hypertension and
Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland; and.
Clin J Am Soc Nephrol. 2015 Nov 6;10(11):2023-9. doi: 10.2215/CJN.10111014. Epub 2015 Sep 4.
Previous studies demonstrated a higher risk of CKD in persons with a history of kidney stones, but these studies examined mostly white populations and did not evaluate important potential interactions such as race and plasma uric acid.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In 10,678 Atherosclerosis Risk in Communities (ARIC) study participants free of CKD at baseline (ARIC visit 4 in 1996-1998), we assessed the association between a history of nephrolithiasis (a time-varying variable, defined by a combination of self-report and diagnostic codes) and incident CKD (defined by diagnostic codes from linkage to hospitalizations and US Centers for Medicare and Medicaid Services' records).
At baseline, 856 participants had a history of nephrolithiasis; 322 developed nephrolithiasis during follow-up. Over a mean follow-up of 12 years, there were 1037 incident CKD events. Nephrolithiasis history was associated with a 29% (hazard ratio [HR], 1.29; 95% confidence interval [95% CI], 1.07 to 1.54) higher risk of CKD in demographic-adjusted analyses, but the association was no longer statistically significant after multivariable adjustment (HR, 1.09; 95% CI, 0.90 to 1.32). The multivariable-adjusted association was stronger among participants with plasma uric acid levels ≤6 mg/dl (HR, 1.34; 95% CI, 1.05 to 1.72) compared with those with levels >6 mg/dl (HR, 0.94; 95% CI, 0.70 to 1.28; P(interaction) = 0.05). There was no interaction of stone disease and race with incident CKD.
In this community-based cohort, nephrolithiasis was not an independent risk factor for incident CKD overall. However, risk of CKD was unexpectedly elevated in participants with stone disease and lower plasma uric acid levels.
既往研究表明,有肾结石病史的人群患慢性肾脏病(CKD)的风险更高,但这些研究大多针对白人人群,且未评估种族和血尿酸等重要潜在相互作用因素。
设计、地点、参与者与测量方法:在社区动脉粥样硬化风险研究(ARIC)的10678名基线时无CKD的参与者中(1996 - 1998年ARIC第4次访视),我们评估了肾结石病史(一个随时间变化的变量,通过自我报告和诊断编码组合定义)与新发CKD(通过与住院记录及美国医疗保险和医疗补助服务中心记录的关联诊断编码定义)之间的关联。
基线时,856名参与者有肾结石病史;322名在随访期间发生肾结石。在平均12年的随访中,有1037例新发CKD事件。在人口统计学调整分析中,肾结石病史与CKD风险升高29%相关(风险比[HR],1.29;95%置信区间[95%CI],1.07至1.54),但在多变量调整后,该关联不再具有统计学意义(HR =1.09;95%CI,0.90至1.32)。与血尿酸水平>6mg/dl的参与者相比(HR =0.94;95%CI,0.70至1.28;交互作用P值 =0.05)血浆尿酸水平≤6mg/dl 的参与者多变量调整后的关联更强。结石病与种族和新发CKD之间没有交互作用。
在这个基于社区的队列研究中,总体而言肾结石不是新发CKD的独立危险因素。然而,患有结石病且血浆尿酸水平较低的参与者患CKD的风险意外升高。